[Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status].
Immunological investigation involving 100 estrogen-progesterone receptor negative (RE-RP-) and 71 estrogen-progesterone receptor positive (RE+RP+) breast cancer patients demonstrated that Ki-67 expression in the former group was twice (49.8%) that in the latter (25.9%). Low Ki-67 expression was found in 39% of RE-RP-tumors whereas high expression--in 28% of RE+RP+ tumors.
Ellinidi
V N
VN
Anikeeva
N V
NV
Goncharova
O A
OA
Krasnozhon
D A
DA
D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology*; D049109:Cell Proliferation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
D019394:Ki-67 Antigen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone